Albuquerque, New Mexico

Tuesday, 10 December 2019 6:00 PM - 8:00 PM MST

2031 Mountain Road Northwest, Albuquerque, New Mexico, 87104, United States

Register Now


Sale ended

MD Partial Approval - Free

sales ended

DO Partial Approval - Free

Sale ended

PA Partial Approval - Free

sales ended

NP Partial Approval - Free

Sale ended

RN Partial Approval - Free

sales ended

Allied Health Professional/Other Partial Approval - Free

Sale ended

MD/DO Fellow or Resident Partial Approval - Free

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Tuesday, 10 December 2019 6:00 PM - 8:00 PM MST

Seasons Grill Old Town, 2031 Mountain Road Northwest, Albuquerque, New Mexico, 87104, United States.

Please note - a separate email address is required for each medical professional attending the program.
Contact us at 207-767-1080 to register by phone.

Suspecting Pulmonary Hypertension in the Dyspneic Patient:
Who, When, and How

Seasons Grill Old Town
Balthazar Room
2031 Mountain Road Northwest
Albuquerque, New Mexico

Sarah K. Medrek, MD
Assistant Professor of Medicine
Pulmonary Hypertension Program
University of New Mexico
New Mexico VA Health Care System

Lana D. Melendres-Groves, MD

Associate Professor of Medicine
Medical Director, Pulmonary Hypertension Program
Division of Pulmonary and Critical Care
Department of Internal Medicine
University of New Mexico
University of New Mexico Hospital

Target Audience
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with pulmonary arterial hypertension (PAH).

Educational Objectives
This CME program is designed to improve competence, performance, and patient care practices by instructing clinicians in the highest quality of care for patients with PAH. At the conclusion of the program, participants should be able to:

  • Accurately diagnose patients through comprehensive screening and early recognition of symptoms
  • Evaluate the patient’s condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
In support of improving patient care, this activity has been planned and implemented by Washington University School of Medicine in St. Louis, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for This Activity
Washington University School of Medicine in St. Louis designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Statement
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, that planners, faculty and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest prior to the educational activity. Faculty must also disclose any planned discussion of unlabled/unapproved uses of drugs or devices during their presentation. Detailed disclosures will be made in activity handout materials.

On-Demand Medical Education Program Committee Members
Deborah J. Levine, MD, FCCP (Committee Chair), University of Texas Health Science Center, San Antonio; James R. Runo, MD, University of Wisconsin School of Medicine and Public Health; Marc Simon, MD, MS, FACC, University of Pittsburg School of Medicine; K. Akaya Smith, MD, Perelman School of Medicine at the University of Pennsylvania; Sean M. Studer, MD, MSc, FCCP, SUNY Downstate College of Medicine; Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP (Advisor), Michigan Medicine

Washington University School of Medicine in St. Louis, CME Reviewers
Murali M. Chakinala, MD, FCCP — Content
Allyson R. Zazulia, MD — CME


This activity is supported by educational grants from:

Diamond Level
Actelion Pharmaceuticals US, Inc.

Gold Level
United Therapeutics Corporation


Cancellation policy

Although there is no cost to you to attend this program, PHA is a patient organization and is charged for meals based upon registrations. Please let us know if you are unable to attend.

The Pulmonary Hypertension Association is committed to providing clinicians and researchers in the field with the most current information on pulmonary hypertension and raising awareness about this challenging disease. One way that we do this is through our medical education programming. For more information about our programs for medical professionals, please visit the link above.

Contact the Organizer